Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential

Discovery of first-in-class medicines for treating cancer is limited by concerns with their toxicity and safety profiles, while repurposing known drugs for new anticancer indications has become a viable alternative. Here, we have developed a new approach that utilizes cell cycle arresting patterns a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Yu-Chen, Senese, Silvia, France, Bryan, Gholkar, Ankur A., Damoiseaux, Robert, Torres, Jorge Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595967/
https://www.ncbi.nlm.nih.gov/pubmed/28900159
http://dx.doi.org/10.1038/s41598-017-11508-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595967/
https://www.ncbi.nlm.nih.gov/pubmed/28900159
http://dx.doi.org/10.1038/s41598-017-11508-2

Ejemplares similares